Abstract
Although ovarian cancer is a devastating disease, we can now offer hope as agents with unique mechanisms of action are developed and elicit favorable response rates in clinical trials.
Original language | English (US) |
---|---|
Pages (from-to) | 81-100 |
Number of pages | 20 |
Journal | Contemporary Ob-Gyn |
Volume | 42 |
Issue number | 7 |
State | Published - 1997 |
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Advanced and Specialized Nursing
- Maternity and Midwifery